首页
1
最新消息
2
活动
3
[Cloud-clone] Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy4
精磊生技实业有限公司 台北市中山区德惠街7-1号810室
On November 11, 2021, Matthias Kettwig, Gogentine University Medical Center, Germany, and his team , published a paper titled "Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy" on Nature Communications, which suggested that RNaseT2-/- mice can be used to study central nervous system damage associated with RnaseT2 defects. https://www.genlabbiotech.com/cn/hot_412970.html [Cloud-clone] Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy 2022-01-10 2023-01-10
精磊生技实业有限公司 台北市中山区德惠街7-1号810室 https://www.genlabbiotech.com/cn/hot_412970.html
精磊生技实业有限公司 台北市中山区德惠街7-1号810室 https://www.genlabbiotech.com/cn/hot_412970.html
https://schema.org/EventMovedOnline https://schema.org/OfflineEventAttendanceMode
2022-01-10 http://schema.org/InStock TWD 0 https://www.genlabbiotech.com/cn/hot_412970.html

On November 11, 2021, Matthias Kettwig, Gogentine University Medical Center, Germany, and his team , published a paper titled "Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy" on Nature Communications, which suggested that RNaseT2-/- mice can be used to study central nervous system damage associated with RnaseT2 defects.

1883777b9ba6456b8b1232e3c508e1f5.jpg
附加档案:
原文Paper.pdf

回列表 下一个